Insider Transactions in Q2 2025 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2025
|
Laura Brege |
SELL
Open market or private sale
|
Direct |
14,446
-48.9%
|
$303,366
$21.78 P/Share
|
|
May 29
2025
|
Laura Brege |
BUY
Exercise of conversion of derivative security
|
Direct |
9,387
+24.11%
|
-
|
|
May 29
2025
|
James M Daly |
BUY
Exercise of conversion of derivative security
|
Direct |
9,387
+21.62%
|
-
|
|
May 29
2025
|
Elizabeth A. Garofalo |
BUY
Exercise of conversion of derivative security
|
Direct |
9,387
+25.81%
|
-
|
|
May 29
2025
|
Edmund Harrigan |
BUY
Exercise of conversion of derivative security
|
Direct |
9,387
+21.13%
|
-
|
|
May 29
2025
|
Adora Ndu |
BUY
Exercise of conversion of derivative security
|
Direct |
9,387
+27.46%
|
-
|
|
May 29
2025
|
Daniel B Soland |
BUY
Exercise of conversion of derivative security
|
Direct |
9,387
+17.57%
|
-
|
|
May 29
2025
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
32,428
+0.24%
|
-
|
|
May 16
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-3.12%
|
$50,000
$25.0 P/Share
|
|
May 16
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-8.56%
|
$88,000
$22.5 P/Share
|
|
May 02
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,327
-5.34%
|
$18,578
$14.6 P/Share
|
|
May 02
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,498
-5.28%
|
$48,972
$14.6 P/Share
|
|
May 01
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,596
+9.46%
|
-
|
|
May 01
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,815
+9.32%
|
-
|
|
Apr 08
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,708
-4.36%
|
$37,912
$14.82 P/Share
|
|
Apr 08
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,028
-4.41%
|
$14,392
$14.82 P/Share
|
|
Apr 05
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,275
+7.82%
|
-
|
|
Apr 05
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+7.95%
|
-
|